James W Verbsky1, Talal A Chatila. 1. aDepartment of Pediatrics, Division of Rheumatology, Medical College of Wisconsin, Milwaukee, Wisconsin bDepartment of Pediatrics, Division of Immunology, The Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Abstract
PURPOSE OF REVIEW: To summarize recent progress in our understanding of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders. RECENT FINDINGS: A number of Mendelian disorders of immune dysregulation and autoimmunity have been noted to result from defects in T regulatory cell, development and function. The best characterized of these is IPEX, resulting from mutations affecting FOXP3. A number of other gene defects that affect T regulatory cell function also give rise to IPEX-related phenotypes, including loss-of-function mutations in CD25, STAT5b and ITCH. Recent progress includes the identification of gain-of-function mutations in STAT1 as a cause of an IPEX-like disease, emerging FOXP3 genotype/phenotype relationships in IPEX, and the elucidation of a role for the microbiota in the immune dysregulation associated with regulatory T cell deficiency. SUMMARY: An expanding spectrum of genetic defects that compromise T regulatory cell function underlies human disorders of immune dysregulation and autoimmunity. Collectively, these disorders offer novel insights into pathways of peripheral tolerance and their disruption in autoimmunity.
PURPOSE OF REVIEW: To summarize recent progress in our understanding of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders. RECENT FINDINGS: A number of Mendelian disorders of immune dysregulation and autoimmunity have been noted to result from defects in T regulatory cell, development and function. The best characterized of these is IPEX, resulting from mutations affecting FOXP3. A number of other gene defects that affect T regulatory cell function also give rise to IPEX-related phenotypes, including loss-of-function mutations in CD25, STAT5b and ITCH. Recent progress includes the identification of gain-of-function mutations in STAT1 as a cause of an IPEX-like disease, emerging FOXP3 genotype/phenotype relationships in IPEX, and the elucidation of a role for the microbiota in the immune dysregulation associated with regulatory T cell deficiency. SUMMARY: An expanding spectrum of genetic defects that compromise T regulatory cell function underlies human disorders of immune dysregulation and autoimmunity. Collectively, these disorders offer novel insights into pathways of peripheral tolerance and their disruption in autoimmunity.
Authors: Solrun Vidarsdottir; Marie J E Walenkamp; Alberto M Pereira; Marcel Karperien; Jaap van Doorn; Hermine A van Duyvenvoorde; Stefan White; Martijn H Breuning; Ferdinand Roelfsema; M Femke Kruithof; Jaap van Dissel; Riny Janssen; Jan M Wit; Johannes A Romijn Journal: J Clin Endocrinol Metab Date: 2006-06-20 Impact factor: 5.958
Authors: Vivian Hwa; Brian Little; Pelin Adiyaman; Eric M Kofoed; Katherine L Pratt; Gonul Ocal; Merih Berberoglu; Ron G Rosenfeld Journal: J Clin Endocrinol Metab Date: 2005-04-12 Impact factor: 5.958
Authors: Andrew L Mellor; Phillip Chandler; Babak Baban; Anna M Hansen; Brendan Marshall; Jeanene Pihkala; Herman Waldmann; Stephen Cobbold; Elizabeth Adams; David H Munn Journal: Int Immunol Date: 2004-09-06 Impact factor: 4.823
Authors: A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler Journal: Science Date: 1998-12-11 Impact factor: 47.728
Authors: Bin Li; Arabinda Samanta; Xiaomin Song; Kathryn T Iacono; Patrick Brennan; Talal A Chatila; Giovanna Roncador; Alison H Banham; James L Riley; Qiang Wang; Yuan Shen; Sandra J Saouaf; Mark I Greene Journal: Int Immunol Date: 2007-06-22 Impact factor: 4.823
Authors: Raymond J Louie; Queenie K-G Tan; Jennifer B Gilner; R Curtis Rogers; Noelle Younge; Stephanie B Wechsler; Marie T McDonald; Barbara Gordon; Christopher A Saski; Julie R Jones; Shelley J Chapman; Roger E Stevenson; John W Sleasman; Michael J Friez Journal: Am J Med Genet A Date: 2017-03-20 Impact factor: 2.802
Authors: Darin L Wiesner; Kyle D Smith; Dmitri I Kotov; Judith N Nielsen; Paul R Bohjanen; Kirsten Nielsen Journal: J Immunol Date: 2015-11-20 Impact factor: 5.422